Targeting Metabolic Remodeling in Glioblastoma Multiforme
2010

Targeting Metabolic Changes in Brain Tumors

publication Evidence: moderate

Author Information

Author(s): Wolf Amparo, Agnihotri Sameer, Guha Abhijit

Primary Institution: The Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children Research Institute, University of Toronto

Hypothesis

Targeting key metabolic enzymes involved in modulating the Warburg Effect may provide a novel therapeutic approach for Glioblastoma Multiforme.

Conclusion

The study suggests that targeting metabolic enzymes in glioblastoma may improve treatment outcomes.

Supporting Evidence

  • GBMs are characterized by a metabolic shift to aerobic glycolysis, known as the Warburg Effect.
  • Targeting metabolic pathways may enhance the effectiveness of existing therapies for glioblastoma.
  • Altered metabolism in tumor cells provides substrates necessary for rapid cell growth.

Takeaway

Cancer cells use sugar differently than normal cells, which helps them grow. This study looks at how changing this sugar use could help treat brain tumors.

Methodology

The review discusses metabolic remodeling in glioblastoma and the role of key enzymes in this process.

Limitations

The review does not provide new experimental data but synthesizes existing literature.

Digital Object Identifier (DOI)

10.18632/oncotarget.190

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication